Form 4: Hims & Hers CEO Shifts Shares Among Trusts

Hims & Hers Health, Inc. CEO Andrew Dudum reported several transfers of Class A and Class V Common Stock among various family and estate planning trusts.

Summary

• Andrew Dudum, CEO, Director, and 10% Owner of Hims & Hers Health, Inc., reported changes in beneficial ownership of Class A and Class V Common Stock.
• Transactions occurred on November 7, 10, and 12, 2025, primarily involving transfers between various family and estate planning trusts.
• On November 7, 2025, 262,423 shares of Class A Common Stock were gifted from the AD 2021 GRAT 2 to the Dudum Legacy 2021 Trust.
• On November 10, 2025, 260,000 shares of Class A Common Stock were distributed pro rata from the Dudum Legacy 2021 Trust to its beneficiaries for bona fide estate planning purposes.
• Also on November 10, 2025, 1,049,692 shares of Class A Common Stock were gifted from the AD 2021 GRAT to the Dudum Family 2021 Trust.
• On November 12, 2025, 1,954,379 shares of Class A Common Stock were gifted from the AD 2023 GRAT to the Dudum Family 2021 Trust.
• The filing also details several annuity payments-in-kind of Class A Common Stock from various GRATs (AD 2021 GRAT, AD 2021 GRAT 2, AD 2022 GRAT 2, AD 2023 GRAT) to the Andrew Dudum 2015 Trust, totaling 550,503 shares.
• A transfer of 586,139 shares of Class V Common Stock occurred from the AD 2023 GRAT dated 9-1-2023 to the Andrew Dudum 2015 Trust dated July 2, 2015.
• These transactions represent internal reallocations of shares among trusts for estate planning purposes and do not involve open market sales or purchases.
• Andrew Dudum is deemed to have sole voting and disposition power over securities held by the AD 2023 GRAT dated 9-1-2023 and the Andrew Dudum 2015 Trust dated July 2, 2015.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to estate planning, which are neutral in terms of company performance or outlook.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Andrew Dudum, CEO and 10% owner, engaged in several transactions involving Class A and Class V Common Stock with various trusts (AD 2021 GRAT, AD 2021 GRAT 2, AD 2022 GRAT, AD 2022 GRAT 2, AD 2022 GRAT 3, AD 2023 GRAT, AD 2025 GRAT, Andrew Dudum 2015 Trust, Dudum Legacy 2021 Trust, Dudum Family 2021 Trust, Dudum Family Community Property Trust, Dudum Family Heritage Trust UAD 8-10-2021) for estate planning purposes. These included gifts, annuity payments-in-kind, and pro rata distributions.

Stakeholder Impact

• These transactions are internal transfers for estate planning purposes and are not expected to have a direct impact on shareholders, employees, customers, suppliers, or creditors.

Key Dates

Recommendation

The Form 4 filing details internal transfers of Hims & Hers Health, Inc. Class A and Class V Common Stock by CEO Andrew Dudum among various family and estate planning trusts. These transactions are for estate planning purposes and do not reflect open market sales or purchases, nor do they indicate any change in the company's operational performance or future outlook. Therefore, they do not warrant a change in investment recommendation based solely on this filing.

Keywords

Hims & Hers Health, HIMS, Andrew Dudum, Form 4, Insider Trading, Beneficial Ownership, Trust Transfers, Estate Planning, Class A Common Stock, Class V Common Stock